L-β-aminoisobutyric acid (L-BAIBA) is a substance identified as a new potential medication for muscle development. According to the article, it can be part of a list of unprecedented drugs that aim to promote muscle growth without the side effects associated with anabolic steroids.
These new drugs, nicknamed 'muscle pens', aim to combat muscle mass loss and the effects of aging. The expectation is that these medications could represent a revolution in the pharmaceutical market, similar to that caused by the so-called 'weight loss pens'.
The article is presented as exclusive for subscribers, with limited access through registration at the publication link.
